sec filing
GT
NASDAQ · GTBP
GT Biopharma, Inc.
Healthcare · Biotechnology
$5.27
Down-$0.43 (-8.07%)
Updated Nov 4, 2026, 8:35 PM
SID Score
5.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 6.84M
- P/E ratio
- -0.27
- Dividend yield
- 0.00%
- 52-week range
- $0.26 – $11.98
- Volume
- 41.65K
- Avg. volume
- 2.07M
Price performance · GTBP
GTBP price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 3, 2026
GTBP closed at $5.27 after 21 trading sessions, down 17.27% for the selected period.
- Last close
- $5.27
- Period change
- -17.27%
- Period low
- $5.07
- Period high
- $7.36
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 3, 2026 | $5.16 | $5.32 | $5.05 | $5.27 | 41.65K |
| Nov 2, 2026 | $5.35 | $5.3988 | $5.11 | $5.13 | 33.59K |
| Oct 30, 2026 | $5.47 | $5.535 | $5.30 | $5.32 | 20.27K |
| Oct 29, 2026 | $5.61 | $5.69 | $5.46 | $5.60 | 57.02K |
| Oct 28, 2026 | $5.39 | $5.69 | $5.32 | $5.51 | 54.78K |
| Oct 27, 2026 | $5.56 | $5.671 | $5.18 | $5.58 | 102.42K |
| Oct 26, 2026 | $5.49 | $5.78 | $5.07 | $5.07 | 178.78K |
| Oct 23, 2026 | $5.58 | $5.70 | $5.31 | $5.46 | 63.92K |
| Oct 22, 2026 | $5.37 | $5.57 | $5.28 | $5.52 | 69.42K |
| Oct 21, 2026 | $6.81 | $6.90 | $5.31 | $5.41 | 170.84K |
| Oct 20, 2026 | $6.63 | $7.49 | $6.63 | $7.31 | 49.37K |
| Oct 19, 2026 | $7.17 | $7.17 | $6.69 | $6.69 | 28.77K |
| Oct 16, 2026 | $7.14 | $7.32 | $6.86 | $7.03 | 55.29K |
| Oct 15, 2026 | $6.50 | $7.40 | $6.50 | $7.36 | 63.08K |
| Oct 14, 2026 | $6.44 | $6.44 | $5.86 | $6.21 | 42.15K |
| Oct 13, 2026 | $7.50 | $7.50 | $6.3282 | $6.50 | 29.57K |
| Oct 12, 2026 | $6.79 | $7.05 | $6.50 | $6.80 | 37.96K |
| Oct 9, 2026 | $5.96 | $6.68 | $5.8269 | $6.68 | 43.38K |
| Oct 8, 2026 | $6.20 | $6.22 | $5.80 | $5.96 | 31.77K |
| Oct 7, 2026 | $6.30 | $6.47 | $6.20 | $6.20 | 19.17K |
| Oct 6, 2026 | $6.31 | $6.45 | $6.20 | $6.37 | 22.4K |
Latest GTBP news
The latest Smart Investors Daily articles mentioning GTBP.
Stock researchResearch & News · News
Company
Market Activity
Research & News
Loading stock research…

